SCHEMBL1818247

SCHEMBL1818247

CCOc1c(B2OC(C)(C)C(C)(C)O2)cc2nccnc2c1F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1817486 0.87 EGFR (0.34)
SCHEMBL3304381 0.83 LPL (0.33)
SCHEMBL3307250 0.74 KDM4E (0.42)
SCHEMBL24707511 0.72 LPL (0.35)
SCHEMBL21823668 0.72 LPL (0.35)
SCHEMBL3312075 0.72 THRB (0.37)
SCHEMBL18935090 0.70 LPL (0.35)
SCHEMBL25220672 0.70 LPL (0.35)
SCHEMBL3304374 0.70 MAPK1 (0.32)
SCHEMBL21823670 0.69 FPR2 (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2321296-A1 SUBSTITUTED 5-AMINOPYRAZOLES AND USE THEREOF Bayer Schering Pharma Aktiengesellschaft (DE) 2011-05-18 EP disclosed
US-20100099681-A1 SUBSTITUTED 5-AMINOPYRAZOLES AND USE THEREOF BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2010-04-22 US disclosed
WO-2010020363-A1 SUBSTITUTED 5-AMINOPYRAZOLES AND USE THEREOF BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2010-02-25 WO disclosed